CA2265926A1 - Methode pour modifier les concentrations d'homocysteine dans le plasma humain - Google Patents

Methode pour modifier les concentrations d'homocysteine dans le plasma humain Download PDF

Info

Publication number
CA2265926A1
CA2265926A1 CA 2265926 CA2265926A CA2265926A1 CA 2265926 A1 CA2265926 A1 CA 2265926A1 CA 2265926 CA2265926 CA 2265926 CA 2265926 A CA2265926 A CA 2265926A CA 2265926 A1 CA2265926 A1 CA 2265926A1
Authority
CA
Canada
Prior art keywords
humans
homocysteine levels
plasma homocysteine
altering plasma
altering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2265926
Other languages
English (en)
Other versions
CA2265926C (fr
Inventor
Airudin S. Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2265926 priority Critical patent/CA2265926C/fr
Priority to PCT/CA1999/000892 priority patent/WO2000061154A1/fr
Priority to AU58447/99A priority patent/AU5844799A/en
Publication of CA2265926A1 publication Critical patent/CA2265926A1/fr
Application granted granted Critical
Publication of CA2265926C publication Critical patent/CA2265926C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
CA 2265926 1999-04-08 1999-04-08 Methode pour modifier les concentrations d'homocysteine dans le plasma humain Expired - Lifetime CA2265926C (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA 2265926 CA2265926C (fr) 1999-04-08 1999-04-08 Methode pour modifier les concentrations d'homocysteine dans le plasma humain
PCT/CA1999/000892 WO2000061154A1 (fr) 1999-04-08 1999-09-27 Composition contenant du soufre sublime permettant d'alterer le taux d'homodyst(e) plasmatique chez les humains
AU58447/99A AU5844799A (en) 1999-04-08 1999-09-27 Composition, containing sublimed sulphur, for altering plasma homodyst(e) levelsin humans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2265926 CA2265926C (fr) 1999-04-08 1999-04-08 Methode pour modifier les concentrations d'homocysteine dans le plasma humain

Publications (2)

Publication Number Publication Date
CA2265926A1 true CA2265926A1 (fr) 2000-10-08
CA2265926C CA2265926C (fr) 2007-01-02

Family

ID=29588566

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2265926 Expired - Lifetime CA2265926C (fr) 1999-04-08 1999-04-08 Methode pour modifier les concentrations d'homocysteine dans le plasma humain

Country Status (1)

Country Link
CA (1) CA2265926C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058300A1 (fr) * 2003-12-18 2005-06-30 London Health Sciences Centre Research Inc. Procede permettant de traiter les niveaux plasmiques eleves d'homocysteine chez des patients souffrant d'irsu
WO2007140588A1 (fr) * 2006-06-02 2007-12-13 Natural Ma Inc. Atténuation d'un agent pathogène par l'administration d'un composé équilibiotique

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058300A1 (fr) * 2003-12-18 2005-06-30 London Health Sciences Centre Research Inc. Procede permettant de traiter les niveaux plasmiques eleves d'homocysteine chez des patients souffrant d'irsu
WO2007140588A1 (fr) * 2006-06-02 2007-12-13 Natural Ma Inc. Atténuation d'un agent pathogène par l'administration d'un composé équilibiotique
CN101500584B (zh) * 2006-06-02 2012-12-12 奈彻若Ma公司 微米级硫磺在预防和治疗人和动物的病原性紊乱中的应用

Also Published As

Publication number Publication date
CA2265926C (fr) 2007-01-02

Similar Documents

Publication Publication Date Title
AU5490199A (en) Process for the purification of 1,3-propanediol
ZA200006042B (en) Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections.
EP0665590A3 (fr) Microstructure mécanique, son procédé de fabrication et dispositifs incorporant cette structure.
AU1238895A (en) The use of benzazoles as UV absorbers, new benzazoles and a process for their preparation
AU2002352832A1 (en) 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and processes for making them
WO2002036106A3 (fr) Nouvelle composition medicamenteuse a base d'anticholinergiques et de corticosteroides
AU2777999A (en) Method for treating plants
AU3727397A (en) Elastomers, processes for their manufacture, and articles made from these elastomers
ZA995444B (en) A method for the treatment of staphylococcal disease.
HUP0401760A3 (en) Stent, process for production thereof and its use for treating for restenosen and/or trombozen
WO2003050137A3 (fr) Mutations de recepteur de type toll 4
CA2265926A1 (fr) Methode pour modifier les concentrations d'homocysteine dans le plasma humain
AU2003215704A1 (en) Method of treating a part in order to alter at least one of the properties thereof
AU2708099A (en) Method for treating soil for the control of soil borne plant pathogens
HK1034706A1 (en) Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
AU5827900A (en) Method for plant water treatment for at least one partially closed water circuit
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
ZA200005016B (en) Shaped body of zeolite, a process for its production and its use.
ZA200102727B (en) Method of treating sickle cell disease or thalassemia.
AU4567696A (en) Process for removing SO2 from gases which contain it, with direct production of elemental sulfur
AU2924400A (en) Plant treatment method
ZA200006166B (en) Substituted sulphonyl cyanamides, method for producing same and their use as medicament.
ZA200101058B (en) Process for the treatment of gases.
AU5844899A (en) Composition, containing sublimed sulfur, for the treatment of lactose intolerance
AU3037000A (en) Agents for treating textiles, method for producing them and their use

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190408